COMMUNIQUÉS West-GlobeNewswire

-
Aveanna to Participate at the Deutsche Bank Healthcare Summit
19/08/2025 -
Altimmune Announces FDA Fast Track Designation for Pemvidutide in Alcohol Use Disorder (AUD)
19/08/2025 -
Angitia Biopharmaceuticals to Present Data on AGA2115 for Osteogenesis Imperfecta at ASBMR 2025
19/08/2025 -
Memo Therapeutics AG Publishes Phase I Safety, Tolerability, and Pharmacokinetics Study for Neutralizing Antibody Targeting BKPyV Infection in Clinical and Translational Science
19/08/2025 -
BioXcel Therapeutics Announces Database Lock in SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia
19/08/2025 -
Teleflex Announces the Launch of Barrigel™ Rectal Spacer in Japan as a Proven Safe and Effective Option to Minimize the Harmful Long-Term Side Effects of Prostate Radiation Therapy
19/08/2025 -
Merakris Therapeutics Receives USPTO Notice of Allowance for Foundational Patent Supporting MTX-001 Biologic Drug Platform
19/08/2025 -
Zymeworks Announces Participation in Upcoming Investor Conferences
19/08/2025 -
Greenwich LifeSciences Announces Plan to Build Out Internal Clinical Operations Team
19/08/2025 -
ITM to Present New Subgroup Analysis Data from the COMPETE Trial at ESMO 2025 and Host an Educational Event for Healthcare Professionals
19/08/2025 -
Scientists Discuss the Recent CancerVax Breakthrough
19/08/2025 -
Coloplast A/S - Interim Financial Report, 9M 2024/25
19/08/2025 -
Coloplast A/S - Announcement no. 05/2025 - Coloplast announces changes to Executive Leadership Team
19/08/2025 -
Basilea on track with strong 2025 half-year results
19/08/2025 -
Santhera Secures Agreement with Uniphar for the Distribution of AGAMREE® (Vamorolone) in five GCC (Gulf Cooperation Council) Countries
19/08/2025 -
argenx to Host R&D Webinar Highlighting ARGX-119 on September 16, 2025
19/08/2025 -
Idorsia publishes end results of repurchase offer for its 2025 and 2028 convertible bonds
19/08/2025 -
CytoMed Therapeutics Limited Announces At-the-Market (ATM) Offering Program
19/08/2025 -
Sienna Announces Offering of $175 Million of 4.112% Series E Senior Unsecured Debentures and Closing of Previously Announced Acquisition in Greater Toronto Area
19/08/2025
Pages